share_log

Cadrenal Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Quang X. Pham(48.57%),The PVBQ Living Trust(23.04%)

Cadrenal Therapeutics | SC 13G:超過5%持股股東披露文件-Quang X. Pham(48.57%),The PVBQ Living Trust(23.04%)

SEC announcement ·  02/12 21:45
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息